Navigation Links
Oregon study raises questions on synthetic progestins
Date:3/10/2008

The widely used synthetic progestin medroxyprogesterone acetate (MPA) decreased endothelial function in premenopausal women in a study done at the University of Oregon. The finding, researchers said, raises concerns about long-term effects of MPA and possibly other synthetic hormones on vascular health in young women.

The vascular endothelium lines the inside of blood vessels. In recent years, it has been found to be a dynamic organ that serves an important role in the prevention of atherosclerosis.

"The logical conclusion of this study is that over a long period of time it would not be good to have exposure to an agent that is reducing blood vessel flexibility, because it could be associated with the development of heart disease or related problems," said co-author Dr. Paul F. Kaplan, a long-time Eugene gynecologist and senior researcher in the UO's human physiology department. He stressed, however, that a longer, larger study is needed.

MPA is the progestin that was used in the Women's Health Initiative (WHI), including a clinical study on hormone-replacement therapy halted because of health concerns in postmenopausal women. MPA is the active ingredient of Provera, which is used to treat abnormal uterine bleeding, induce menstrual cycles and relieve symptoms of the menopause.

It's also a component in Depo/Provera, an injectible long-lasting contraceptive used by many young women. Millions of women use various hormone therapies with a variety of progestin types for contraception. In the U.S. alone, 80 percent of women have used oral contraceptives.

The UO study, appearing online ahead of regular publication by the journal Heart and Circulatory Physiology, is among the first to focus on the impact of MPA in premenopausal women. Fourteen women, 19-27 years old, took part in the study after passing thorough medical exams to screen out numerous health conditions.

The five-member UO team -- led by Jessica R. Meendering, a former UO doctoral student now a professor of exercise science at the University of Nebraska in Omaha -- studied the effects of the sex hormone estradiol by itself and in combination with MPA on endothelial function of the brachial artery. The health of the endothelium in this artery has been shown to be a telling proxy for the coronary arteries and a good predictor of cardiovascular risk.

When researchers gave an oral version of MPA to determine its impact, they found that it wiped out the positive effects on endothelial function that estradiol had provided. MPA reduced the function by reducing the brachial artery's ability to dilate -- grow bigger in diameter -- in response to the stress of changing blood flow, Kaplan said.

UO researchers also found that MPA had an effect on concentrations of endothelin-1, a peptide that promotes cell division and serves as a mediator of inflammation. It also acts as a constricting factor for blood vessels. When peptide levels rise, endothelin-1 is suspected to play a key role in many diseases of the airways, pulmonary circulation, inflammatory lung diseases and vasoconstriction of blood vessels. UO researchers saw levels decline with estradiol alone, but increase substantially with the addition of MPA, negating the benefits of the estrogen.

"There is an overwhelming amount of evidence to suggest that estrogen is beneficial to arterial vascular health of women," Meendering said. "Since the WHI found either no benefit or a slight increase in adverse cardiovascular events in postmenopausal women taking combination hormone-replacement therapy containing estrogen and MPA, many have questioned the vascular effects MPA and its use in postmenopausal women. This led our group to question how MPA affects the vasculature in young women.

"We need to be taking the time to find out if different synthetic hormones have different effects on vascular health in young women," she said. "It's not a big health concern right now, because there are no obvious short-term effects raising health concerns. But we don't know how these synthetic hormones taken by young women affect their long-term cardiovascular health. Maybe effects aren't being noticed while women are young, but maybe they are adding to the fact that rates of cardiovascular disease are so high in women."

Kaplan stressed that this project was a starting point of "major basic science research, so this study does not say women should change what they are doing."

"We can say that we saw vascular changes in the arteries of the arm that have been shown in previous studies involving coronary arteries," he added. "This study does let us say that whatever changes we are seeing are important not just for the arm but probably for most of the major arteries in the body, and this is important for cardiac disease."


'/>"/>

Contact: Jim Barlow
jebarlow@uoregon.edu
541-346-3491
University of Oregon
Source:Eurekalert  

Related medicine news :

1. Providence Health & Services - Oregon Region Powers Consumer Portal With Kryptiq Connect IQ
2. Oregon researchers discover a mechanism leading to cleft palate
3. Oregon researchers find trigger gene for muscle development
4. TriWest Contributes $30,000 to Oregon National Guard Fund
5. Tobacco Industry Puts Profits Before Kids in Defeating Oregon Ballot Initiative
6. Big Tobacco Spends Record $12 Million to Deceive Oregon Voters
7. New Report: Increasing Oregons Cigarette Tax Will Reduce Smoking, Save Lives and Save Money
8. The First Mega-Shelter Arrangement in Oregon Created for Major Disaster Response and Recovery
9. Details of Oregon Wine Regions First Luxury Inn, Spa Revealed at Groundbreaking Ceremony
10. Big Tobaccos Latest Dirty Trick: Deceiving Oregon Voters
11. Oregon Scientific to Sponsor First-Ever Rock Concert on Mount Everest
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Oregon study raises questions on synthetic progestins
(Date:2/27/2017)... ... February 27, 2017 , ... Anahata Ananda of Shamangelic ... happy to announce her “Spring Rejuvenation in Sedona” personally tailored retreats. For those ... the winter-weary soul an excellent opportunity to come out of hibernation and do ...
(Date:2/27/2017)... ... ... Elisa Guajardo Carothers is not your typical author. She went from working as a movie ... writes about God, when she isn’t swimming as a performing mermaid. , Her book isn’t ... Satan),” she offers a comedic look at the dysfunctions of God’s family, before Lucifer was ...
(Date:2/27/2017)... (PRWEB) , ... February 26, 2017 , ... Miro is ... pioneer sound and video system brings songs, movies, TV shows and much more apps ... offers clear, high-definition sound. An immersive view of 1280 x 720 provides crisp images ...
(Date:2/27/2017)... BC (PRWEB) , ... February 27, 2017 , ... ... drug rehabilitation and alcohol treatment programs in British Columbia, Canada, at https://www.sunshinecoasthealthcentre.ca/ ... to its team. The new hire, Mackenzie Alsager, showcases the Centre's commitment to ...
(Date:2/27/2017)... ... February 27, 2017 , ... New Jersey ranks among the ... types and genders. And the need for advanced services is growing. , Project ... cancer care program, in collaboration with their non-profit partners in their fight against cancer ...
Breaking Medicine News(10 mins):
(Date:2/28/2017)... Calif. , Feb. 28, 2017  Rigel ... that it will report its fourth quarter and ... Tuesday, March 7, 2017.  Rigel senior management will ... and webcast at 5:00pm Eastern Time (2:00pm Pacific ... Participants can access the live conference call by ...
(Date:2/28/2017)... YORK , Feb. 27, 2017  Market Research presents ... global medical fiber optics market titled ,Medical Fiber Optics Market: ... market dynamics and trends globally across the five key regions ... America , Europe , APAC and ... the global medical fiber optics market over the forecast period. ...
(Date:2/28/2017)... LONDON , Feb. 27, 2017 This ... understand Takeda and its partnering interests and activities since ... Description The Partnering Deals and Alliance ... partnering activity of one of the world,s leading life ... prepared upon purchase to ensure inclusion of the most ...
Breaking Medicine Technology: